Discover

ITCI
Intra-Cellular Therapies, Inc.
131.87
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd57.89%
1y97.80%
131.87
day range
131.87
64.09
52 week range
131.98
Open131.87Prev Close131.87Low131.87High131.87Mkt Cap14.05B
Vol16.04MAvg Vol3.62MEPS-0.73P/E-180.64Forward P/E507.19
Beta0.46Short Ratio1.20Inst. Own96.45%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg129.42200-d Avg92.671yr Est132.00

ITCI News

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

VOQUEZNA launch momentum continues with over 390,000 prescriptions filled to date, written by more t

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
businesswire.com
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Fo

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
businesswire.com
ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, In

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
zacks.com
ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenu

Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates
zacks.com
Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates

Intra-Cellular Therapies (ITCI) came out with a quarterly loss of $0.16 per share versus the Zacks C

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results
globenewswire.com
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million , representing a 51% increase o

Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
cnbc.com
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders
prnewswire.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders

NEW YORK , Jan. 16, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investiga

Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer
zacks.com
Intra-Cellular Therapies Stock Up 34% on J&J's $14.6B Buyout Offer

JNJ is set to acquire ITCI for $132 per share in cash. The transaction is likely to close before thi

Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last?
zacks.com
Intra-Cellular (ITCI) Moves 34.1% Higher: Will This Strength Last?

Intra-Cellular (ITCI) witnessed a jump in share price last session on above-average trading volume.

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
businesswire.com
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Fo

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders
businesswire.com
Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Intra-Cellular Therapies (Nasdaq: ITCI) for p

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal
https://thefly.com
BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal

Intra-Cellular +32.49 (+34.25%) Johnson & Johnson +2.22 (+1.56%)

ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz
zacks.com
ITCI Stock Rises 15% on Settling Caplyta Patent Litigation With Sandoz

Intra-Cellular stock gains 15% as it settles Caplyta patent litigation with Sandoz protecting the dr

Drugmakers rush to sign deals on first day of industry conference
reuters.com
Drugmakers rush to sign deals on first day of industry conference

Drugmakers signed deals worth at least $18 billion in combined value on Monday, the first day of the

Intra-Cellular just downgraded at Morgan Stanley, here's why
https://thefly.com
Intra-Cellular just downgraded at Morgan Stanley, here's why

Intra-Cellular +32.2 (+33.94%) Johnson & Johnson +1.38 (+0.97%)

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B
investopedia.com
Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B

Shares of Intra-Cellular Therapies (ITCI) are surging 35% in premarket trading Monday after Johnson

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, Inc. Is Fair to Shareholders
businesswire.com
ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-Cellular Therapies, In

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Intra-Cellular (ITCI) Surges 14.9%: Is This an Indication of Further Gains?
zacks.com
Intra-Cellular (ITCI) Surges 14.9%: Is This an Indication of Further Gains?

Intra-Cellular (ITCI) was a big mover last session on higher-than-average trading volume. The latest

J&J to buy Intra-Cellular Therapies for $14.6 billion
reuters.com
J&J to buy Intra-Cellular Therapies for $14.6 billion

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for about $14.6 bil

Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
benzinga.com
Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last

Top performers in last week's stock market: Walgreens, Constellation Energy, FTAI Aviation, TD S

benzinga.com
Earnings Scheduled For February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For November 2, 2023

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

benzinga.com
Earnings Scheduled For August 3, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

benzinga.com
Earnings Scheduled For May 4, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

benzinga.com
Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day

Gainers

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 497 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For November 3, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

benzinga.com
Earnings Scheduled For August 9, 2022

  Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022

Upgrades

benzinga.com
Earnings Scheduled For May 10, 2022

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly

benzinga.com
Earnings Scheduled For November 9, 2021

  Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

  Before 10 a.m. ET on Thursday, 258 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    During Wednesday's morning trading, 251 companies set new 52-week highs.

benzinga.com
Earnings Scheduled For May 10, 2021

  Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its fir

benzinga.com
Earnings Scheduled For February 25, 2021

  Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings

benzinga.com
Stocks That Hit 52-Week Highs On Friday

    Friday morning saw 331 companies set new 52-week highs.

benzinga.com
52 Weeks High Article 0.004831689889895241

  Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET on Friday, 202 companies set new 52-we

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

Before 10 a.m. ET on Thursday, 394 companies hit new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

    On Tuesday, 596 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Monday

    Monday morning saw 558 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 192 companies set new 52-week highs.

benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018

benzinga.com
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018

Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018